Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease

NCT03048526 is registered in ClinicalTrials.gov with Novaliq GmbH as lead sponsor.

NCT NCT03048526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03048526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease
Lead sponsor
Novaliq GmbH
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2016
Completion date
April 18, 2017
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease